Range Low Price High Price Comment
30 days $9.09 $9.09 Friday, 22nd Sep 2023 CTIC stock ended at $9.09. During the day the stock fluctuated 0% from a day low at $9.09 to a day high of $9.09.
90 days $9.09 $9.09
52 weeks $4.01 $9.10

Historical CTI BioPharma Corp. prices

Date Open High Low Close Volume
2020-05-06 $1.05 $1.08 $1.00 $1.01 206 226
2020-05-05 $1.02 $1.06 $1.02 $1.04 138 124
2020-05-04 $1.05 $1.07 $1.00 $1.01 230 928
2020-05-01 $1.00 $1.04 $0.98 $1.00 186 098
2020-04-30 $1.06 $1.08 $1.00 $1.03 380 510
2020-04-29 $1.18 $1.18 $1.05 $1.08 428 366
2020-04-28 $1.15 $1.18 $1.10 $1.13 881 324
2020-04-27 $0.99 $1.19 $0.96 $1.08 2 371 213
2020-04-24 $0.89 $0.90 $0.88 $0.88 49 924
2020-04-23 $0.88 $0.90 $0.87 $0.89 57 514
2020-04-22 $0.87 $0.91 $0.86 $0.88 51 636
2020-04-21 $0.89 $0.91 $0.86 $0.89 119 281
2020-04-20 $0.92 $0.92 $0.89 $0.90 131 282
2020-04-17 $0.88 $0.92 $0.88 $0.91 89 655
2020-04-16 $0.90 $0.93 $0.88 $0.88 173 366
2020-04-15 $0.96 $0.96 $0.89 $0.89 160 139
2020-04-14 $0.94 $0.96 $0.91 $0.94 71 305
2020-04-13 $0.95 $0.96 $0.91 $0.92 151 403
2020-04-09 $0.92 $0.98 $0.92 $0.95 82 705
2020-04-08 $0.93 $0.95 $0.93 $0.95 72 032
2020-04-07 $0.95 $0.97 $0.91 $0.95 57 716
2020-04-06 $0.93 $0.97 $0.90 $0.96 109 910
2020-04-03 $0.96 $0.96 $0.90 $0.95 69 757
2020-04-02 $0.93 $0.97 $0.93 $0.96 145 919
2020-04-01 $0.95 $0.95 $0.91 $0.93 86 277
Click to get the best stock tips daily for free!

About CTI BioPharma Corp.

CTI BioPharma CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.;... CTIC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT